Neutrophil Gelatinase Associated Lipocalin (NGAL) in Leptospirosis Acute Kidney Injury: A Multicenter Study in Thailand
Male
Science
Lipocalin
Urine
Kidney
03 medical and health sciences
0302 clinical medicine
Lipocalin-2
Proto-Oncogene Proteins
Sepsis
Dipstick
Pathology
Humans
Leptospirosis
Internal medicine
Immunology and Microbiology
Leptospira
Q
R
Life Sciences
Recovery of Function
Acute Kidney Injury
Middle Aged
Thailand
Lipocalins
Leptospirosis: Zoonotic Disease and Global Impact
Acute kidney injury
3. Good health
Treatment Outcome
Medicine
Female
Parasitology
Dialysis
Biomarkers
Research Article
Acute-Phase Proteins
DOI:
10.1371/journal.pone.0143367
Publication Date:
2015-12-02T18:59:53Z
AUTHORS (25)
ABSTRACT
AKI is one of the most serious complications leptospirosis, an important zoonosis in tropics. Recently, NGAL, novel biomarkers, extensively studied various specific settings such as sepsis, cardiac surgery, and radiocontrast nephropathy. In this multicenter study, we aimed to study role NGAL early marker outcome predictor leptospirosis associated AKI. Patients who presented with clinical suspiciousness were prospectively enrolled 9 centers from August 2012 November 2014. The first day enrollment was suspicious leptospirosis. Blood urine samples serially collected on three days 7 after enrollment. We used standard techniques (microscopic agglutination test, direct culture, PCR technique) confirm diagnosis KDIGO criteria for diagnosis. Recovery defined alive not requiring dialysis during hospitalization or maintaining maximum stage at hospital discharge. Of 221 recruited cases, 113 cases confirmed cases. Thirty seven percent developed Median uNGAL pNGAL levels those developing significantly higher than patients [253.8 (631.4) vs 24.1 (49.6) ng/ml, p < 0.001] [1,030 (802.5) 192.0 (209.0) 0.001], respectively. had AUC-ROC 0.91, 0.92, Both level between AKI-recovery group AKI-non recovery comparable. From provided promising result be a However, both them did show potential renal setting.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (36)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....